Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version, MENQOL-Intervention questionnaire

Maturitas

Volumn 50, Issue 3, 2005, Pages 209-221

  Lewis, Jacqueline E ^a,c   Hilditch, John R ^a   Wong, Cindy J ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Measurement; Menopause; Menopause Specific Quality of Life questionnaire; Psychometric properties; Quality of life

Indexed keywords

SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEX HORMONE;

ADULT; ARTICLE; BREAST TENDERNESS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HUMAN; LEG CRAMP; MATHEMATICAL COMPUTING; MENOPAUSE; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SPOTTING; STATISTICAL SIGNIFICANCE; VAGINA BLEEDING; VALIDATION PROCESS; VASOMOTOR REFLEX;

EID: 13944266042     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.06.015     Document Type: Article

References (37)

1. J.R. Hilditch, J. Lewis, and A. Peter A Menopause-Specific Quality of Life questionnaire: development and psychometric properties Maturitas 24 1996 161 175
2. Mapi Research Institute, 27 Rue de la Villette, 69003 Lyon, France.
3. J.R. Hilditch, S. Chen, P.G. Norton, and J. Lewis Experience of menopausal symptoms by Chinese and Canadian women Climacteric 2 1999 164 173
4. B. Neugarten, and R. Kraines Menopausal symptoms in women of various ages Psychosom Med 28 1965 266 273
5. G.H. Guyatt, S.J. Veldhuyzen Van Zanten, D.H. Feeny, and D.L. Patrick Measuring quality of life in clinical trials: a taxonomy and review CMAJ 140 1989 1441 1448
6. R. Deyo, P. Diehr, and D. Patrick Reproducibility and responsiveness of health status measures: statistics and strategies for evaluation Control Clin Trials 12 1991 1425 1585
7. G.H. Guyatt, B. Kirshner, and R. Jaeschke Measuring health status: what are the necessary measurement properties? J Clin Epidemiol 45 1992 1341 1345
8. G.H. Guyatt, C. Bombardier, and P.X. Tugwell Measuring disease-specific quality of life in clinical trials CMAJ 134 1986 889 895
9. R. Jaeschke, and G. Guyatt Quality of life assessments in clinical trials 1990 Raven Press, Ltd. New York
10. P.M. Fayers, and D.J. Hand Factor analysis, causal indicators and quality of life Qual Life Res 6 1997 139 150
11. G.H. Guyatt, C.D. Naylor, E. Juniper, D.K. Heyland, R. Jaeschke, and D.J. Cook Users' guides to the medical literature. XII How to use articles about health-related quality of life: evidence-based medicine working group JAMA 277 1997 1232 1237
12. P.M. Fayers, D.J. Hand, K. Bjordal, and M. Groenvold Causal indicators in quality of life research Qual Life Res 6 1997 393 406
13. R. Likert A technique for the development of attitude scales Educ Psycholog Meas 12 1952 313 315
14. P. Bech Quality of life in psychosomatic research: a psychometric model Psychopathology 20 1987 169 179
15. Reading effectiveness tool. Clear language and design. Accessed December 19, 2003, 〈http://www.eastendliteracy.on.ca/ClearLnguageAndDesign/ readingeffectivenesstool/〉.
16. Canadian Pharmacists Association. Compendium of Pharmaceuticals and Specialties. The Canadian Drug Reference for Health Professionals. Ottawa: Canadian Pharmacists Association, 2000.
17. Mapi Research Institute. QOLID, the Quality of Life Instruments Database. Accessed May 28, 2004, 〈http://www.qolid.org〉.
18. J. Lewis, L. Nickell, L. Thompson, J. Szalai, and J. Hilditch The effect of flaxseed, soyflour and wheat muffins on quality of life: an RCT Menopause 9 2002 488 P-437
19. M.M. Gelfand, M. Moreau, N.J. Ayotte, J.R. Hilditch, B.A. Wong, and C.Y. Lau Clinical assessment and quality of life of post-menopausal women treated with a new intermittent progestogen combination hormone replacement therapy: a placebo-controlled study Menopause 10 2003 29 36
20. Mapi Research Institute. Linguistic validation of the Menopause-Specific Quality of Life Questionnaire into Canadian French. Unpublished report, November 1999.
21. M. Blatt, H. Wiesbader, and H. Kupperman Vitamin E and climacteric syndrome Arch Intern Med 91 1953 793 799
22. P. Bech, N. Munk-Jensen, E.B. Obel, L.G. Ulrich, P. Eiken, and S.P. Nielsen Combined versus sequential hormonal replacement therapy: a double-blind, placebo-controlled study on quality of life-related outcome measures Psychother Psychosom 67 1998 259 265
23. L. Aday Designing and conducting health surveys 1989 Jossey-Bass San Francisco
24. G. Guyatt, S. Walter, and G. Norman Measuring change over time: assessing the usefulness of evaluative instruments J Chronic Dis 40 1987 171 178
25. J. Sloan Methodologic lessons learned from hot flash studies J Clin Oncol 19 2001 4280 4290
26. M. Limouzin-Lamothe, N. Mairon, C. Joyce, and M. Le Gal Quality of life after the menopause: influence of hormonal replacement therapy Am J Obstet Gynecol 170 1994 618 624
27. I. Wiklund, J. Holst, and J. Karlberg A new methodological approach to the evaluation of quality of life in post-menopausal women Maturitas 14 1992 211 224
28. G. Hauser, I. Huber, P. Keller, C. Lauritzen, and H. Schneider Evaluation of menopausal symptoms Menopause Rating Scale (MRS) Zentralbl Gynakol 116 1994 16 23
29. W.H. Utian, J.W. Janata, S.A. Kingsberg, M. Schluchter, and J.C. Hamilton The Utian Quality of Life (UQOL) Scale: development and validation of an instrument to quantify quality of life through and beyond menopause Menopause 9 2002 402 410
30. I. Wiklund Methods of assessing the impact of climacteric complaints on quality of life Maturitas 29 1998 41 50
31. E. Alder The Blatt-Kupperman menopausal index: a critique Maturitas 29 1998 19 24
32. P. Potthoff, A. Heinemenn, H. Schneider, H. Rosemeier, and G. Hauser Menopause Rating Scale (MRS II): methodological standardization in the population of Germany Zentralbl Gynakol 5 2000 280 286
33. H.P. Schneider, H.P. Rosemeier, J. Schnitker, S. Gerbsch, and R. Turck Application and factor analysis of the menopause rating scale [MRS] in a post-marketing surveillance study of Climen Maturitas 37 2000 113 124
34. H.P. Schneider, L.A. Heinemann, H.P. Rosemeier, P. Potthoff, and H.M. Behre The Menopause Rating Scale (MRS): reliability of scores of menopausal complaints Climacteric 3 2000 59 64
35. H.P. Schneider, L.A. Heinemann, H.P. Rosemeier, P. Potthoff, and H.M. Behre The Menopause Rating Scale (MRS): comparison with Kupperman index and quality-of-life scale SF-36 Climacteric 3 2000 50 58
36. www.hqlo.com/content/1/1/28, accessed March 8, 2004.
37. J.M. Lachin Introduction to sample size determination and power analysis for clinical trials Control Clin Trials 2 1981 93 113